|
KR100491282B1
(ko)
|
1996-07-24 |
2005-05-24 |
워너-램버트 캄파니 엘엘씨 |
통증 치료용 이소부틸가바 및 그의 유도체
|
|
DE69834204T2
(de)
*
|
1997-10-27 |
2007-03-29 |
Warner-Lambert Co. Llc |
Zyklische aminosäuren und deren derivate als arzneimittel
|
|
US6984659B2
(en)
|
1997-11-18 |
2006-01-10 |
Klinikum Der Albert-Ludwigs Universitaet |
2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level
|
|
DE19751062A1
(de)
*
|
1997-11-18 |
1999-07-08 |
Univ Ludwigs Albert |
An 4-Stellung substituierte 2-Pyrrolidinon-Derivate zur Verringerung des extrazellulären Glutamat-Spiegels
|
|
WO1999031075A1
(en)
*
|
1997-12-16 |
1999-06-24 |
Warner-Lambert Company |
1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
|
|
NZ508490A
(en)
|
1998-07-09 |
2003-08-29 |
Warner Lambert Co |
Use of a combination of a GABA analog and caffeine as an analgesic
|
|
EP1031350A1
(en)
*
|
1999-02-23 |
2000-08-30 |
Warner-Lambert Company |
Use of a gabapentin-analog for the manufacture of a medicament for preventing and treating visceral pain
|
|
US6992109B1
(en)
*
|
1999-04-08 |
2006-01-31 |
Segal Catherine A |
Method for the treatment of incontinence
|
|
HRP20010581A2
(en)
*
|
1999-12-08 |
2002-08-31 |
Warner Lambert Co |
Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
|
|
JP2003528148A
(ja)
*
|
2000-03-28 |
2003-09-24 |
デロレンゾ、ロバート・ジェイ |
損傷に際して神経細胞中に形成される新規カルシウム損傷電流の阻害は神経細胞死を抑制する
|
|
GB2362646A
(en)
*
|
2000-05-26 |
2001-11-28 |
Warner Lambert Co |
Cyclic amino acid derivatives useful as pharmaceutical agents
|
|
DE10048715A1
(de)
*
|
2000-09-30 |
2004-05-19 |
Grünenthal GmbH |
Verwendung von Aminosäure zur Behandlung von Schmerz
|
|
WO2002032376A2
(en)
*
|
2000-10-06 |
2002-04-25 |
Xenoport, Inc. |
Bile-acid conjugates for providing sustained systemic concentrations of drugs
|
|
EP1343805A4
(en)
|
2000-10-06 |
2005-07-20 |
Xenoport Inc |
COMPOUNDS DERIVED FROM GALLENIC ACIDS FOR THE PROVISION OF CONTINUING SYSTEMIC CONCENTRATIONS OF MEDICINAL PRODUCTS AFTER ORAL ADMINISTRATION
|
|
US6683112B2
(en)
*
|
2000-10-24 |
2004-01-27 |
Andrx Corporation |
Gabapentin prodrugs and formulations
|
|
GB2368579A
(en)
*
|
2000-10-31 |
2002-05-08 |
Parke Davis & Co Ltd |
Azole pharmaceutical agents
|
|
CN1471507A
(zh)
|
2000-11-02 |
2004-01-28 |
������ҩ��ҵ����˾ |
用于制备加巴喷丁中间体的改进方法
|
|
US20040063994A1
(en)
*
|
2001-03-16 |
2004-04-01 |
Paolo Rossi |
Process for the preparation of cyclic amino acids
|
|
WO2002100347A2
(en)
*
|
2001-06-11 |
2002-12-19 |
Xenoport, Inc. |
Prodrugs of gaba analogs, compositions and uses thereof
|
|
US6818787B2
(en)
|
2001-06-11 |
2004-11-16 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
US8048917B2
(en)
|
2005-04-06 |
2011-11-01 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
US7232924B2
(en)
|
2001-06-11 |
2007-06-19 |
Xenoport, Inc. |
Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
|
|
US7186855B2
(en)
|
2001-06-11 |
2007-03-06 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
|
WO2002100344A2
(en)
*
|
2001-06-11 |
2002-12-19 |
Xenoport, Inc. |
Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
|
|
US20060167032A1
(en)
*
|
2002-01-16 |
2006-07-27 |
Galer Bradley S |
Pharmaceutical composition and method for treating disorders of the central nervous system
|
|
US6927036B2
(en)
|
2002-02-19 |
2005-08-09 |
Xero Port, Inc. |
Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
|
|
AU2003222033A1
(en)
*
|
2002-03-20 |
2003-10-08 |
Xenoport |
Cyclic 1-(acyloxy)-alkyl prodrugs of gaba analogs, compositions and uses thereof
|
|
US20050153928A1
(en)
*
|
2002-05-07 |
2005-07-14 |
Holick Michael F. |
Conjugates comprising a central nervous system-active drug linked to glucuronic acid or glucosamine through an amide bond and uses thereof
|
|
WO2003099338A2
(en)
|
2002-05-17 |
2003-12-04 |
Xenoport, Inc. |
Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
|
|
AU2003297927A1
(en)
*
|
2002-12-11 |
2004-06-30 |
Xenoport, Inc. |
Prodrugs of fused gaba analogs, pharmaceutical compositions and uses thereof
|
|
US20040162351A1
(en)
*
|
2002-12-11 |
2004-08-19 |
Gallop Mark A. |
Orally administered dosage forms of fused GABA analog prodrugs having reduced toxicity
|
|
ES2341240T3
(es)
|
2002-12-13 |
2010-06-17 |
Warner-Lambert Company Llc |
Ligando alfa-2-delta para tratar los sintomas del tracto urinario inferior.
|
|
CA2451267A1
(en)
|
2002-12-13 |
2004-06-13 |
Warner-Lambert Company Llc |
Pharmaceutical uses for alpha2delta ligands
|
|
GB0301143D0
(en)
*
|
2003-01-17 |
2003-02-19 |
Amedis Pharm Ltd |
Compounds and their use
|
|
MXPA05010515A
(es)
*
|
2003-03-31 |
2006-03-10 |
Xenoport Inc |
Tratamiento o prevencion de sofocos calientes utilizando profarmacos de analogos de gaba.
|
|
CA2537837A1
(en)
|
2003-09-11 |
2005-03-24 |
Xenoport, Inc. |
Treating and/or preventing urinary incontinence using prodrugs of gaba analogs
|
|
MXPA06002789A
(es)
|
2003-09-12 |
2006-06-14 |
Pfizer |
Combinaciones que comprenden ligandos alfa-2-delta.
|
|
MXPA06003043A
(es)
*
|
2003-09-17 |
2006-05-31 |
Xenoport Inc |
Tratamiento o prevencion del sindrome piernas inquietas utilizando prodrogas de analogos gaba.
|
|
WO2005037784A2
(en)
*
|
2003-10-14 |
2005-04-28 |
Xenoport, Inc. |
Crystalline form of gamma-aminobutyric acid analog
|
|
PL1691811T3
(pl)
|
2003-12-11 |
2014-12-31 |
Sunovion Pharmaceuticals Inc |
Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
|
|
US20050209332A1
(en)
*
|
2004-03-17 |
2005-09-22 |
Hikal Limited |
Gabapentin analogues and process thereof
|
|
US7632864B2
(en)
*
|
2004-03-17 |
2009-12-15 |
Hikal Ltd. |
Gabapentin analogues and process thereof
|
|
EP1763503A1
(en)
|
2004-03-17 |
2007-03-21 |
Hikal Limited |
4-t-butylgabapentin and its synthesis
|
|
EP1811986B1
(en)
*
|
2004-11-04 |
2014-03-26 |
XenoPort, Inc. |
Gabapentin prodrug sustained release oral dosage forms
|
|
WO2008073257A1
(en)
*
|
2006-12-08 |
2008-06-19 |
Xenoport, Inc. |
Use of prodrugs of gaba analogs for treating diseases
|
|
UA94979C2
(uk)
|
2006-12-22 |
2011-06-25 |
Рекордати Айеленд Лимитед |
КОМБІНОВАНА ТЕРАПІЯ ПОРУШЕНЬ НИЖНІХ СЕЧОВИВІДНИХ ШЛЯХІВ ЛІГАНДАМИ α2δ І НПЗП
|
|
US8828665B2
(en)
|
2007-02-16 |
2014-09-09 |
Ark Diagnostics, Inc. |
Compounds and methods for use in detecting gabapentin
|
|
TW200908957A
(en)
*
|
2007-06-15 |
2009-03-01 |
Xenoport Inc |
Use of prodrugs of GABA analogs, antispasticity agents, and prodrugs of GABAB receptor agonists for treating spasticity
|
|
TW200936123A
(en)
*
|
2007-11-06 |
2009-09-01 |
Xenoport Inc |
Use of prodrugs of GABAb agonists for treating neuropathic and musculoskeletal pain
|
|
US7872046B2
(en)
|
2008-01-25 |
2011-01-18 |
Xenoport, Inc. |
Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use
|
|
JP5563483B2
(ja)
|
2008-01-25 |
2014-07-30 |
ゼノポート，インコーポレイティド |
アシロキシアルキルカルバメートプロドラッグの合成に使用されるアシロキシアルキルチオカーボネートの鏡像異性的な分解
|
|
WO2009094577A2
(en)
|
2008-01-25 |
2009-07-30 |
Xenoport, Inc. |
Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
|
|
BRPI0919811B1
(pt)
|
2008-10-08 |
2022-04-19 |
Xgene Pharmaceutical Inc |
Conjugados de gaba e métodos de uso dos mesmos
|
|
WO2010048423A1
(en)
|
2008-10-24 |
2010-04-29 |
Ark Diagnostics, Inc. |
Levetiracetam immunoassays
|
|
WO2010099200A1
(en)
|
2009-02-24 |
2010-09-02 |
Nektar Therapeutics |
Oligomer-amino acid conjugates
|
|
US20110130454A1
(en)
*
|
2009-11-24 |
2011-06-02 |
Xenoport, Inc. |
Prodrugs of gamma-amino acid, alpha-2-delta ligands, pharmaceutical compositions and uses thereof
|
|
US20110124705A1
(en)
*
|
2009-11-24 |
2011-05-26 |
Xenoport, Inc. |
Prodrugs of alpha-2-delta ligands, pharmaceutical compositions and uses thereof
|
|
US9066853B2
(en)
|
2013-01-15 |
2015-06-30 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable fiber
|
|
US9970929B2
(en)
|
2013-01-18 |
2018-05-15 |
Ark Diagnostics, Inc. |
Voriconazole immunoassays
|
|
AU2014209028C1
(en)
|
2013-01-28 |
2019-08-29 |
Hector L. Lopez |
Methods of improving tolerability, pharmacodynamics, and efficacy of b-alanine and use therefor
|
|
EP2956444B1
(en)
|
2013-02-13 |
2018-05-30 |
ARK Diagnostics, Inc. |
Posaconazole immunoassays
|
|
AU2019271799B2
(en)
|
2018-05-14 |
2023-10-12 |
Xgene Pharmaceutical Inc. |
Crystalline forms of 1-(acyloxy)-alkyl carbamate drug conjugates of naproxen and pregabalin
|